€1.84 billionTotal budget of Global Health EDCTP3
€418 millionFunding for 92 projects with clinical trials and scientific studies
€20 millionFunding for 17 projects that strengthen clinical research capacity in sub-Saharan Africa
49 members of EDCTP Association33 African and 16 European countries
406 participating entitiesfrom 64 countries
33 SMEsparticipating in projects
Our projects
Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...
Accelerating vaccine development for neglected tropical diseasesThe EAVI project is establishing an international partnership to promote the clinical testing of vaccines against neglected...
Monitoring mpox vaccine activity in AfricaThe MpoxVax AFRIVAC project is closing key knowledge gaps on the performance of mpox vaccines in Central Africa.
Building capacity in new drug developmentThe PACoPPDeT project is developing a cohort of researchers with a deep understanding of all aspects of pharmaceutical product development.
Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...
Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).
TB prevention in people living with diabetesThe EDCTP2-funded PROTID project has received additional Global Health EDCTP3 funding, enabling it to complete its trial of preventive TB...
Protecting antibiotic potencyThe ASPIRE project is assessing whether improved infection prevention and control, coupled with more personalised antibiotic use, can reduce pressures driving...
Our community speaks
‘My message to any young researcher that's considering applying to EDCTP is: do it!’Catherine Hankins, Senior Fellow at the Amsterdam Institute for Global Health & Development
‘This programme facilitates collaboration between North and South and invests in innovation and development of the next generation.’John Gyapong, Vice-chairperson of the Global Health EDCTP3 Scientific Committee
‘Global Health EDCTP3 is unique in addressing the gaps: strengthening the capacity and the innovation components that are essential for the developing countries.’Eleni Aklilu, Professor of Tropical Pharmacology
